Journal of Biomarkers in Drug Development Open Access

  • Journal h-index: 1
  • Journal CiteScore: 80.00
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Aim and Scope

Journal of Biomarkers in Drug Development is open access,interdisciplinary journal for the rapid publication of original articles and reviews that emphasis on basic research in vital areas of Biomarkers.  drives the development of new predictive, diagnostic and prognostic techniques, and also plays an important role in the discovery and development of new drugs. Biomarkers in Medicine advances understanding in the potential and actual applications of this research, translating knowledge into the clinic and increasing the effectiveness of medical practice.High-quality, methodologically sound papers are considered in the following areas, with manuscripts presenting multicenter human studies and clinical trials being given particular priority:

•           Predictive, diagnostic and prognostic biomarkers

•           Biomarkers in drug discovery and development, including  pharmacokinetic/pharmacodynamics modelling and simulation

•           Biomarkers for clinical safety assessment and predicting adverse effects

•           Biomarkers in treatment decision making and monitoring

•           Optimum biomarker selection, validation and application

•           Bioanalytical method development and validation

•           Impact of biomarkers on medicine, including regulatory and ethical issues

The journal welcomes unsolicited article proposals, including for the submission of original research, narrative and systematic reviews, and opinion pieces. The journal offers rapid and open access publishing options.